1. |
Preminger GM, Assimos DG, Lingeman JE, et al. Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol, 2005, 173(6): 1991-2000.
|
2. |
Bazin D, André G, Weil R, et al. Absence of bacterial imprints on struvite-containing kidney stones: a structural investigation at the mesoscopic and atomic scale. Urology, 2012, 79(4): 786-790.
|
3. |
Williams JJ, Rodman JS, Peterson CM. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med, 1984, 311(12): 760-764.
|
4. |
de Cógáin MR, Lieske JC, Vrtiska TJ, et al. Secondarily infected nonstruvite urolithiasis: a prospective evaluation. Urology, 2014, 84(6): 1295-1300.
|
5. |
那彦群, 叶章群, 孙颖浩, 等. 中国泌尿外科疾病诊断治疗指南. 北京: 人民卫生出版社, 2013: 95.
|
6. |
Park HS, Lee SY, Kim SM, et al. Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation. Diabetes Care, 2006, 29(4): 933-934.
|
7. |
Bichler KH, Eipper E, Naber K, et al. Urinary infection stones. Int J Antimicrob Agents, 2002, 19(6): 488-498.
|
8. |
Hesse A, Heimbach D. Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review. World J Urol, 1999, 17(5): 308-315.
|
9. |
叶章群. 泌尿系结石研究现况与展望. 中华实验外科杂志, 2005, 22(3): 261-262.
|
10. |
Flannigan R, Choy WH, Chew B, et al. Renal struvite stones: pathogenesis, microbiology, and management strategies. Nat Rev Urol, 2014, 11(6): 333-341.
|
11. |
Usui Y, Matsuzaki S, Matsushita K, et al. Urolithiasis in geriatric patients. Tokai J Exp Clin Med, 2003, 28(2): 81-87.
|
12. |
Krambeck AE, Lieske JC, Li X, et al. Effect of age on the clinical presentation of incident symptomatic urolithiasis in the general population. J Urol, 2013, 189(1): 158-164.
|
13. |
Bichler KH, Henzler B, Strohmaier WL, et al. The significance of citrate, uromucoid and GAG for diagnosis of renal tubular acidosis in patients with urinary calculi. Urologe A, 1995, 34(6): 437-443.
|
14. |
Tefekli A, Kurtoglu H, Tepeler K, et al. Does the metabolic syndrome or its components affect the outcome of percutaneous nephrolithotomy?. J Endourol, 2008, 22(1): 35-40.
|
15. |
Jeong IG, Kang T, Bang JK, et al. Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis, 2011, 58(3): 383-388.
|
16. |
Taylor EN, Stampfer MJ, Obesity CG, et al. Obesity, weight gain, and the risk of kidney stones. JAMA, 2005, 293(4): 455-462.
|
17. |
Ando R, Suzuki S, Nagaya T, et al. Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population. Int J Urol, 2011, 18(2): 131-138.
|
18. |
Sakhaee K, Maalouf NM. Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol, 2008, 28(2): 174-180.
|
19. |
Cho ST, Jung SI, Myung SC, et al. Correlation of metabolic syndrome with urinary stone composition. Int J Urol, 2013, 20(2): 208-213.
|
20. |
Jung HS, Chang IH, Kim KD, et al. Possible relationship between metabolic syndrome traits and nephrolithiasis: incidence for 15 years according to gender. Korean J Urol, 2011, 52(8): 548-553.
|
21. |
Wilding JP. The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors. Metabolism, 2014, 63(10): 1228-1237.
|
22. |
Cameron MA, Maalouf NM, Adams-Huet B, et al. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol, 2006, 17(5): 1422-1428.
|
23. |
Wilke T, Böttger B, Berg B, et al. Healthcare burden and costs associated with urinary tract infections in type 2 diabetes mellitus patients: an analysis based on a large sample of 456,586 German patients. Nephron, 2016, 132(3): 215-226.
|
24. |
Remer T. Influence of nutrition on acid-base balance: metabolic aspects. Eur J Nutr, 2001, 40(5): 214-220.
|
25. |
Cicerello E, Mangano M, Cova GD, et al. Metabolic evaluation in patients with infected nephrolithiasis: is it necessary?. Arch Ital Urol Androl, 2016, 88(3): 208-211.
|
26. |
Nishio S, Abe Y, Wakatsuki A, et al. Matrix glycosaminoglycan in urinary stones. J Urol, 1985, 134(3): 503-505.
|
27. |
Iida S, Suzuki K, Matsuoka K, et al. Analysis of glycosaminoglycans in human prostate by high-performance liquid chromatography. Br J Urol, 1997, 79(5): 763-769.
|
28. |
Torzewska A, Różalski A. In vitro studies on the role of glycosaminoglycans in crystallization intensity during infectious urinary stones formation. APMIS, 2014, 122(6): 505-511.
|
29. |
Englert KM, Mcateer JA, Lingeman JE, et al. High carbonate level of apatite in kidney stones implies infection, but is it predictive?. Urolithiasis, 2013, 41(5): 389-394.
|
30. |
唐寅, 程鸿明, 王坤杰, 等. 四川省 243 例泌尿系结石成分及相关因素分析. 现代泌尿外科杂志, 2016, 21(1): 27-30.
|
31. |
徐勋, 赵振华, 石明, 等. 1168 例泌尿系结石患者结石成分分析及其饮食预防指导. 临床泌尿外科杂志, 2014(8): 694-696.
|
32. |
张锐, 楚宁, 梁凯, 等. 黑龙江省 628 例尿路结石成分分析. 临床泌尿外科杂志, 2016(8): 737-739.
|